Two days post-stroke and 1 day post-NSCs injection, Gsdmd expression showed the greatest increase in the NSCs medium-treated group (Group C), followed by the NSCs-treated group (Group D), while untreated animals showed lower levels. Here, GSDMD is linked to stroke disorder.